AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Negotiating Lower Drug Prices for Affordable Healthcare
Countries worldwide negotiate drug prices with the pharmaceutical industry to ensure affordability. The US is taking steps to cap insulin costs for seniors at $35 per month and reduce prices of asthma inhalers. Commitments from major manufacturers aim to limit inhaler costs to $35. Efforts are in progress to extend the $2,000 cap on prescription drug costs to all Americans, irrespective of the number of chronic illnesses or medications used, significantly reducing the financial burden.